Dr Joseph Y Rudnick, MD in Clifton Park, NY - General Practice

Dr Joseph Y Rudnick, MD is a General Practice physician based in Clifton Park, New York. Dr Joseph Y Rudnick is licensed to practice in New York (license number 1125061) and his current practice location is 615 Route 146a, Clifton Park, New York. He can be reached at his office (for appointments etc.) via phone at (518) 371-4610.

NPI number for Dr Joseph Y Rudnick is 1326016155 and his current mailing address is 615 Route 146a, Clifton Park, New York. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1326016155.

Contact Information

	Dr Joseph Y Rudnick, MD
	615 Route 146a, Clifton Park, NY 12065-1606
	(518) 371-4610
	(518) 371-8307

Physician's Profile

Full Name	Dr Joseph Y Rudnick
Gender	Male
Speciality	General Practice
Location	615 Route 146a, Clifton Park, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1326016155
Provider Enumeration Date: 03/09/2006
Last Update Date: 06/24/2010

Medical Identifiers

Medical identifiers for Dr Joseph Y Rudnick such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1326016155	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	1125061 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Joseph Y Rudnick is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Joseph Y Rudnick, MD 615 Route 146a, Clifton Park, NY 12065-1606 Ph: (518) 371-4610	Dr Joseph Y Rudnick, MD 615 Route 146a, Clifton Park, NY 12065-1606 Ph: (518) 371-4610

News Archive

Older women destined to develop AD have high blood levels of pregnancy protein

In an advance toward a much-needed early diagnostic test for Alzheimer's disease (AD), scientists have discovered that older women destined to develop AD have high blood levels of a protein linked to pregnancy years before showing symptoms.

Blood test detects mild traumatic brain injury for up to a week

Researchers report findings of a blood biomarker that consistently detects mild to moderate traumatic brain injury for up to 7 days and quantifies the degree of damage.

Surgery best for degenerative spondylolisthesis with spinal stenosis

In one of the three most common back conditions for which patients seek treatment, surgery proved to have substantially better results than non-surgical remedies, according to Dartmouth-led research published in the May 31 New England Journal of Medicine.

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.

Tulane professor wins Department of Defense grant for research into arteriovenous malformations

Tulane University's Stryder Meadows, a cell and molecular biology professor, received a $1.7 million grant from the Department of Defense to study how arteriovenous malformations (AVM), which are defects in arteries, veins and capillaries, form Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects about 1 in 5,000 people.

Dr Joseph Y Rudnick, MD - General Practice in Clifton Park, NY